News Related to Dexamethasone

Related coverage linked through entity extraction aliases.

AbbVie Projects Strong 2026 Growth as Skyrizi and Rinvoq Replace Humira

Feb 13, 2026

AbbVie projects 43-45% earnings growth in 2026 as newer immunology drugs Skyrizi and Rinvoq offset declining Humira sales, while maintaining its 54-year dividend increase streak as a Dividend King.

FDA Approves Pembrolizumab Combinations for Platinum-Resistant Ovarian Cancer

Feb 12, 2026

The FDA approved pembrolizumab (Keytruda) and Keytruda Qlex plus paclitaxel, with or without bevacizumab, for adults with PD-L1+ platinum-resistant ovarian carcinoma based on Phase 3 trial data showing improved survival outcomes.